Bregal Sagemount and Ardian have made a strategic growth investment in Ennov, a Paris-based provider of regulatory, quality, and clinical software solutions for the life sciences sector.
Founded and headquartered in Paris, Ennov provides a compliance platform for global life sciences and healthcare companies, supporting regulatory, quality, clinical, commercial and pharmacovigilance workflows through a unified system of record. The company’s platform is designed to replace fragmented point solutions and legacy infrastructure, enabling customers to manage complex regulatory requirements across authorities such as the FDA and EMA within a single environment.
Developed over more than 25 years, Ennov today serves approximately 650 customers and more than 500,000 users across 30 countries.